These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25902902)

  • 21. [Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
    Aldershvile J; Abildgaard U
    Ugeskr Laeger; 1985 Jun; 147(24):1948-9. PubMed ID: 4024344
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial.
    Sanu O
    Obstet Gynecol; 2015 Mar; 125(3):741-742. PubMed ID: 25730246
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.
    Tarhan F; Çelik O; Tosun Ç; Faydacı G; Eryıldırım B
    Urol Int; 2014; 93(1):17-21. PubMed ID: 24643055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis.
    Jansen R; Niemeyer MG; Cleophas TJ; Zwinderman AH
    Angiology; 2000 Dec; 51(12):1007-12. PubMed ID: 11132992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isosorbide-5-mononitrate and endothelial function: a wolf in sheep's clothing.
    Rassaf T; Kelm M
    Eur Heart J; 2013 Nov; 34(41):3173-4. PubMed ID: 23008510
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of isosorbide-5-mononitrate on the tolerance test to exertion in angina pectoris].
    Cherchi A; Lai C; Onnis E; Cherchi A; Meloni L; Pirisi R
    Cardiologia; 1985 Jun; 30(6):439-48. PubMed ID: 3833355
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
    MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
    [No Abstract]   [Full Text] [Related]  

  • 32. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
    Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
    Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isosorbide mononitrate for angina.
    Med Lett Drugs Ther; 1992 Jun; 34(873):61. PubMed ID: 1608345
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluorescent sensing for some nitric oxide donors in dosage forms and biological matrices.
    Talaat W; ElOnsy S; Keshk RM
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Aug; 257():119788. PubMed ID: 33894636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat.
    Mourelle M; Martin MT; Giménez F
    Proc West Pharmacol Soc; 2011; 54():89-93. PubMed ID: 22423590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitric oxide and airway reactivity.
    Strapkova A; Nosalova G
    Bratisl Lek Listy; 2001; 102(8):345-50. PubMed ID: 11763662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
    Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
    Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
    [No Abstract]   [Full Text] [Related]  

  • 39. Nitric oxide mediates cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Boris B; Edwin Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):761-5. PubMed ID: 17291656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of NO donors in substituting impaired endogenous NO production: a functional and morphological study.
    Gerová M; Kristek F
    Physiol Res; 2001; 50(2):165-73. PubMed ID: 11522044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.